209 related articles for article (PubMed ID: 36646701)
1. Dynamic physiological α-synuclein S129 phosphorylation is driven by neuronal activity.
Ramalingam N; Jin SX; Moors TE; Fonseca-Ornelas L; Shimanaka K; Lei S; Cam HP; Watson AH; Brontesi L; Ding L; Hacibaloglu DY; Jiang H; Choi SJ; Kanter E; Liu L; Bartels T; Nuber S; Sulzer D; Mosharov EV; Chen WV; Li S; Selkoe DJ; Dettmer U
NPJ Parkinsons Dis; 2023 Jan; 9(1):4. PubMed ID: 36646701
[TBL] [Abstract][Full Text] [Related]
2. Dynamic reversibility of α-synuclein serine-129 phosphorylation is impaired in synucleinopathy models.
Ramalingam N; Brontesi L; Jin SX; Selkoe DJ; Dettmer U
EMBO Rep; 2023 Dec; 24(12):e57145. PubMed ID: 37870370
[TBL] [Abstract][Full Text] [Related]
3. Polo-like kinase 2 inhibition reduces serine-129 phosphorylation of physiological nuclear alpha-synuclein but not of the aggregated alpha-synuclein.
Elfarrash S; Jensen NM; Ferreira N; Schmidt SI; Gregersen E; Vestergaard MV; Nabavi S; Meyer M; Jensen PH
PLoS One; 2021; 16(10):e0252635. PubMed ID: 34613964
[TBL] [Abstract][Full Text] [Related]
4. Physiological roles of α-synuclein serine-129 phosphorylation - not an oxymoron.
Ramalingam N; Haass C; Dettmer U
Trends Neurosci; 2024 Jun; ():. PubMed ID: 38862330
[TBL] [Abstract][Full Text] [Related]
5. A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein.
Landeck N; Hall H; Ardah MT; Majbour NK; El-Agnaf OM; Halliday G; Kirik D
Mol Neurodegener; 2016 Aug; 11(1):61. PubMed ID: 27549140
[TBL] [Abstract][Full Text] [Related]
6. Specific Detection of Physiological S129 Phosphorylated α-Synuclein in Tissue Using Proximity Ligation Assay.
Arlinghaus R; Iba M; Masliah E; Cookson MR; Landeck N
J Parkinsons Dis; 2023; 13(2):255-270. PubMed ID: 36847016
[TBL] [Abstract][Full Text] [Related]
7. Generation of monoclonal antibodies against phosphorylated α-Synuclein at serine 129: Research tools for synucleinopathies.
Fayyad M; Majbour NK; Vaikath NN; Erskine D; El-Tarawneh H; Sudhakaran IP; Abdesselem H; El-Agnaf OMA
Neurosci Lett; 2020 Apr; 725():134899. PubMed ID: 32156613
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation modulates clearance of alpha-synuclein inclusions in a yeast model of Parkinson's disease.
Tenreiro S; Reimão-Pinto MM; Antas P; Rino J; Wawrzycka D; Macedo D; Rosado-Ramos R; Amen T; Waiss M; Magalhães F; Gomes A; Santos CN; Kaganovich D; Outeiro TF
PLoS Genet; 2014 May; 10(5):e1004302. PubMed ID: 24810576
[TBL] [Abstract][Full Text] [Related]
9. Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease.
Febbraro F; Sahin G; Farran A; Soares S; Jensen PH; Kirik D; Romero-Ramos M
Neurobiol Dis; 2013 Aug; 56():47-58. PubMed ID: 23567651
[TBL] [Abstract][Full Text] [Related]
10. Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade?
Oueslati A
J Parkinsons Dis; 2016; 6(1):39-51. PubMed ID: 27003784
[TBL] [Abstract][Full Text] [Related]
11. α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity.
Ghanem SS; Majbour NK; Vaikath NN; Ardah MT; Erskine D; Jensen NM; Fayyad M; Sudhakaran IP; Vasili E; Melachroinou K; Abdi IY; Poggiolini I; Santos P; Dorn A; Carloni P; Vekrellis K; Attems J; McKeith I; Outeiro TF; Jensen PH; El-Agnaf OMA
Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2109617119. PubMed ID: 35353605
[TBL] [Abstract][Full Text] [Related]
12. Excess phosphoserine-129 α-synuclein induces synaptic vesicle trafficking and declustering defects at a vertebrate synapse.
Wallace JN; Crockford ZC; Román-Vendrell C; Brady EB; Hoffmann C; Vargas KJ; Potcoava M; Wegman ME; Alford ST; Milovanovic D; Morgan JR
Mol Biol Cell; 2024 Jan; 35(1):ar10. PubMed ID: 37991902
[TBL] [Abstract][Full Text] [Related]
13. Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity.
Lashuel HA; Mahul-Mellier AL; Novello S; Hegde RN; Jasiqi Y; Altay MF; Donzelli S; DeGuire SM; Burai R; Magalhães P; Chiki A; Ricci J; Boussouf M; Sadek A; Stoops E; Iseli C; Guex N
NPJ Parkinsons Dis; 2022 Oct; 8(1):136. PubMed ID: 36266318
[TBL] [Abstract][Full Text] [Related]
14. Transgenic mice expressing S129 phosphorylation mutations in α-synuclein.
Escobar VD; Kuo YM; Orrison BM; Giasson BI; Nussbaum RL
Neurosci Lett; 2014 Mar; 563():96-100. PubMed ID: 24486885
[TBL] [Abstract][Full Text] [Related]
15. Phospho-S129 Alpha-Synuclein Is Present in Human Plasma but Not in Cerebrospinal Fluid as Determined by an Ultrasensitive Immunoassay.
Cariulo C; Martufi P; Verani M; Azzollini L; Bruni G; Weiss A; Deguire SM; Lashuel HA; Scaricamazza E; Sancesario GM; Schirinzi T; Mercuri NB; Sancesario G; Caricasole A; Petricca L
Front Neurosci; 2019; 13():889. PubMed ID: 31507364
[TBL] [Abstract][Full Text] [Related]
16. Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains.
Walker DG; Lue LF; Adler CH; Shill HA; Caviness JN; Sabbagh MN; Akiyama H; Serrano GE; Sue LI; Beach TG;
Exp Neurol; 2013 Feb; 240():190-204. PubMed ID: 23201181
[TBL] [Abstract][Full Text] [Related]
17. Increased oligomerization and phosphorylation of α-synuclein are associated with decreased activity of glucocerebrosidase and protein phosphatase 2A in aging monkey brains.
Liu G; Chen M; Mi N; Yang W; Li X; Wang P; Yin N; Li Y; Yue F; Chan P; Yu S
Neurobiol Aging; 2015 Sep; 36(9):2649-59. PubMed ID: 26149921
[TBL] [Abstract][Full Text] [Related]
18. Investigating the presence of doubly phosphorylated α-synuclein at tyrosine 125 and serine 129 in idiopathic Lewy body diseases.
Fayyad M; Erskine D; Majbour NK; Vaikath NN; Ghanem SS; Sudhakaran IP; Abdesselem H; Lamprokostopoulou A; Vekrellis K; Morris CM; Attems J; El-Agnaf OMA
Brain Pathol; 2020 Jul; 30(4):831-843. PubMed ID: 32324926
[TBL] [Abstract][Full Text] [Related]
19. Alpha-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells.
Smith WW; Margolis RL; Li X; Troncoso JC; Lee MK; Dawson VL; Dawson TM; Iwatsubo T; Ross CA
J Neurosci; 2005 Jun; 25(23):5544-52. PubMed ID: 15944382
[TBL] [Abstract][Full Text] [Related]
20. SMG1 identified as a regulator of Parkinson's disease-associated alpha-synuclein through siRNA screening.
Henderson-Smith A; Chow D; Meechoovet B; Aziz M; Jacobson SA; Shill HA; Sabbagh MN; Caviness JN; Adler CH; Driver-Dunckley ED; Beach TG; Yin H; Dunckley T
PLoS One; 2013; 8(10):e77711. PubMed ID: 24204929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
